Avyakta Kallam
-
- Chronic Lymphocytic Leukemia Research 13
- Otorhinolaryngology top 10%
-
- Lymphoma Diagnosis and Treatment 26
-
- CAR-T cell therapy research 17
- Viral-associated cancers and disorders 5
-
- CNS Lymphoma Diagnosis and Treatment 7
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Acute Lymphoblastic Leukemia research 5
-
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Julie M. VoseLynette M. SmithR. Gregory BociekAdams K. AppiahVinicius ErnaniApar Kishor GantiPeter T. SilbersteinValerie Shostrom
- Journals
- Journal of Clinical Oncology (6 papers)Blood (11 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- United StatesSwitzerlandIndia
In The Last Decade
Avyakta Kallam
42 papers receiving 248 citations
Peers
Comparison fields: 5 of 50
- Genetics 66
- Otorhinolaryngology 27
- Pathology and Forensic Medicine 102
- Oncology 104
- Hematology 27
Countries citing papers authored by Avyakta Kallam
This map shows the geographic impact of Avyakta Kallam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avyakta Kallam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avyakta Kallam more than expected).
Fields of papers citing papers by Avyakta Kallam
This network shows the impact of papers produced by Avyakta Kallam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avyakta Kallam. The network helps show where Avyakta Kallam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Avyakta Kallam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 26 | |
| 11 | Cancer, Clear Cell Renal Carcinoma | 2020 | 2 |
| 12 | Fenbendazole as a Treatment for Diffuse Large B-CellLymphoma | 2020 | 1 |
| 13 | 2020 | 0 | |
| 14 | 2020 | 2 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 19 | |
| 17 | 2019 | 34 | |
| 18 | 2019 | 5 | |
| 19 | 2018 | 5 | |
| 20 | 2014 | 15 |
About Avyakta Kallam
Avyakta Kallam is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 52 papers that have together received 249 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (26 papers), CAR-T cell therapy research (17 papers), Chronic Lymphocytic Leukemia Research (13 papers), CNS Lymphoma Diagnosis and Treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Viral-associated cancers and disorders (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Genetics (66 citations), Otorhinolaryngology (27 citations) and Pathology and Forensic Medicine (102 citations). Avyakta Kallam has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Julie M. Vose, Lynette M. Smith, R. Gregory Bociek, Adams K. Appiah, Vinicius Ernani, Apar Kishor Ganti, Peter T. Silberstein, Valerie Shostrom, Jamés O. Armitage and Ariel Modrykamien. Their work appears in journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.